Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02407509 |
|---|---|
| Brief Title: | Phase I Trial of VS-6766 Alone and in Combination With Everolimus (RAF/MEK) |
| First Submitted : | February 9, 2015 |
| First Submitted that Met QC Criteria : | April 2, 2015 |
| First Posted : | April 3, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 25, 2022 |
| Last Update Posted : | May 2, 2022 |